Article
EGFR Mutational Profiling in Non-Small Cell Lung Cancer: The Clinical Performance of a Sensitive Reverse-Hybridization Assay.
Applied immunohistochemistry & molecular morphology : AIMM - 1 Jul 2018
Kriegshäuser Gernot, Enko Dietmar, Novy Michael, Reitmayr Anita, Loidl Almute, Halwachs-Baumann Gabriele, Oberkanins Christian
Abstract excerpt
In patients with non-small cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR) mutations have been associated with the tumor response to targeted therapy with EGFR tyrosine kinase inhibitors. Although labor intensive and not very sensitive (ie, an analytical sensitivity of 20%), direct sequencing is widely used for mutation detection. This study aimed at evaluating the potential of a test...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
